OVIT

OncoVista Innovative The... (CE) (OVIT)

OncoVista Innovative Therapies Inc (CE)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:OVIT

1 2 3 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2016/05/10	03 : 23	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
2016/04/27	23 : 02	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
2016/04/08	19 : 03	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
2016/02/04	20 : 05	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
2015/11/12	20 : 10	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
2015/09/09	00 : 18	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
2015/08/15	03 : 43	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
2015/05/16	04 : 15	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
2015/04/16	00 : 20	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
2015/03/24	01 : 06	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
2015/01/13	05 : 52	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
2014/11/13	21 : 50	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
2014/08/13	04 : 22	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
2014/06/20	03 : 03	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
2014/05/10	03 : 53	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
2014/03/28	19 : 29	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
2014/02/15	01 : 51	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
2014/01/31	20 : 04	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
2013/08/15	02 : 13	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
2013/05/15	05 : 47	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
2013/04/01	19 : 53	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
2013/02/14	23 : 20	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
2013/02/14	23 : 20	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
2012/11/08	02 : 33	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
2012/11/08	02 : 33	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
2012/08/16	02 : 44	Marketwired	Midday Movers on the OTCBB: HPCS, AMPW, OVIT, CSWG	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
2012/08/15	06 : 06	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
2012/07/10	21 : 00	Marketwired	FDA Approves OncoVista's Phase I Clinical Trial of New Drug Candidate (OVI-117) for Solid Tumors	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
2012/05/16	04 : 20	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)
2012/03/31	03 : 23	Edgar (US Regulatory)	Annual Report (10-K)	USOTC:OVIT	OncoVista Innovative Therapies Inc (CE)